Chemoresistance and predictive factors to tumor response and stromal microenvironment 

01/10/2020

ALKBH3 biomarker helps predict Hodgkin lymphoma aggressiveness

24/08/2020

IDIBELL scientists fins a new combination of drugs to treat rhabdomyosarcoma, a highly aggressive tumor in children

01/07/2020

The combination of four drugs at low doses is more effective and less toxic in the treatment of a lung cancer type

15/05/2020

IDIBELL has participated in a study that describes that the ability to produce proteins defines tumor stem cells

07/05/2020

A new study analyzes the molecular concordance between primary colorectal cancer tumors and their respective liver metastasis

03/03/2020

IDIBELL holds the Kickoff Meeting AES 2019 Health Research Projects funded by the ISCIII

28/01/2020

Inhibition of p38 reduces the growth of lung tumors

16/09/2019

Discovered a molecule that regulates the development of cancer in a variety of human tumors

10/07/2019

Scientists Determine a mechanism that would allow treating more aggressive tumors

16/04/2019

IDIBELL – ICO researchers set new bases to develop therapies against colorectal cancer

Scroll to Top